Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis

Written by ClinicalTrials.gov

Category: Muscle Diseases

Published: 28 December 2010

Condition: Myasthenia Gravis
Interventions: Drug: Placebo; Drug: 250 mg CK-2017357; Drug: 500 mg CK-2017357
Sponsors: Cytokinetics; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified August 2011

Details: Last Updated: 28 December 2010

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies